×
0.012911555842479 0.012911555842479 -0.0309877340219497 -0.0309877340219497 -0.0619754680438992 -0.0619754680438992 -0.0477727566171724 -0.0581020012911556
Stockreport

Spero Therapeutics Highlights SPR741 Phase 1 and Preclinical Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases

SPERO THERAPEUTICS (SPRO)  More Company Research Source: GlobeNewswire
US:NASDAQ Investor Relations: investors.sperotherapeutics.com/overview
PDF CAMBRIDGE, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant bacterial infections, announced today one oral presentation and seven poster presentations on SPR741 at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held April 21-24, 2018 in Madrid, Spain. Presentations will include data from the Company’s Phase 1 single-ascending dose (SAD) and multiple-ascending dose (MAD) clinical trial of SPR741 as well as other preclinical studies of SPR741 as a single agent and in combination with other standard-of-care agents for Gram-negative infections. “The data to be presented at ECCMID highlight the anticipated utility of our Potentiator Platform and we believe validate this novel approach to treat multidrug-resistant Gram-negative infections,” said Ankit Mahadevia, M [Read more]

IMPACT SNAPSHOT EVENT TIME: SPRO
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS